Cholesterol Disorders

Bempedoic acid is the first oral, once-daily, non-statin cholesterol lowering medication to receive FDA approval since 2002.

Dyslipidemia guidelines from the US and Europe take slightly different routes to similar ends. Test your knowledge of the twists and turns.

The European and American guidelines on dyslipidemia management overlap but also diverge in critical ways. A Johns Hopkins cardiologist highlights similarities and differences.